Report Content
Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Mesenchymal stem cells industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Products & services trends
2.1.4 Type trends
2.1.5 Source trends
2.1.6 Indication trends
2.1.7 Application trends
Chapter 3 Mesenchymal Stem Cells Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing awareness regarding regenerative medicine
3.2.1.2 Evolving diverse applications of mesenchymal stem cells
3.2.1.3 Rising prevalence of chronic diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of associated with stem cell treatment
3.2.2.2 Lack of standardized & regulated delivery of stem cell therapy
3.3 Growth potential analysis
3.3.1 By products & services
3.3.2 By type
3.3.3 By source
3.3.4 By indication
3.3.5 By application
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Mesenchymal Stem Cells Market, By Products & Services, 2018 - 2032 (USD Million)
5.1 Key trends, by products & services
5.2 Products
5.2.1 Kits, media, & reagents
5.2.2 Cells & cell lines
5.2.3 Other products
5.3 Services
Chapter 6 Mesenchymal Stem Cells Market, By Type, 2018 - 2032 (USD Million)
6.1 Key trends, by type
6.2 Autologous
6.3 Allogeneic
Chapter 7 Mesenchymal Stem Cells Market, By Source, 2018 - 2032 (USD Million)
7.1 Key trends, by source
7.2 Adipose tissue
7.3 Bone marrow
7.4 Cord blood
7.5 Fetal liver
7.6 Fallopian tube
7.7 Lung
7.8 Peripheral blood
7.9 Other sources
Chapter 8 Mesenchymal Stem Cells Market, By Indication, 2018 - 2032 (USD Million)
8.1 Key trends, by indication
8.2 Bone & cartilage repair
8.3 Cardiovascular diseases
8.4 Inflammatory and immunological diseases
8.5 Liver diseases
8.6 Cancer
8.7 Graft versus host disease (GvHD)
8.8 Other indications
Chapter 9 Mesenchymal Stem Cells Market, By Application, 2018 - 2032 (USD Million)
9.1 Key trends, by application
9.2 Disease modeling
9.3 Drug development & discovery
9.4 Stem cell banking
9.5 Tissue engineering
9.6 Toxicology studies
9.7 Other applications
Chapter 10 Mesenchymal Stem Cells Market, By Region, 2018 - 2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 MEA
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of MEA
Chapter 11 Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.2 Cell Applications, Inc.
11.3 Cyagen Biosciences
11.4 Axol Bioscience Ltd.
11.5 Stemedica Cell Technologies, Inc.
11.6 Merck KGaA
11.7 Lonza
11.8 Celprogen Inc.
11.9 PromoCell GmbH
11.10 STEMCELL Technologies
